In one paragraphArticle in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Henrique Previtalli-SilvaLaboratory of Protozoology, Oswaldo Cruz Institute, FIOCRUZ, Av. Brasil, 4.365, Manguinhos, Rio de Janeiro 21040-360, Brazil.ORCID 0009-0005-3305-929X Daiana de Jesus HardoimLaboratory of Protozoology, Oswaldo Cruz Institute, FIOCRUZ, Av. Brasil, 4.365, Manguinhos, Rio de Janeiro 21040-360, Brazil.
Raphael de Lucena BanaggiaLaboratory of Protozoology, Oswaldo Cruz Institute, FIOCRUZ, Av. Brasil, 4.365, Manguinhos, Rio de Janeiro 21040-360, Brazil.ORCID 0009-0000-1531-6452 Carla J Moragas-TellisLaboratory of Natural Products for Public Health, Pharmaceutical Technology Institute (Farmanguinhos), FIOCRUZ, R. Sizenando Nabuco, 100, Manguinhos, Rio de Janeiro 21040-360, Brazil.
Paulo Victor Ramos de SouzaLaboratory of Natural Products for Public Health, Pharmaceutical Technology Institute (Farmanguinhos), FIOCRUZ, R. Sizenando Nabuco, 100, Manguinhos, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0003-4732-3571 Maria Dutra BehrensLaboratory of Natural Products for Public Health, Pharmaceutical Technology Institute (Farmanguinhos), FIOCRUZ, R. Sizenando Nabuco, 100, Manguinhos, Rio de Janeiro 21040-360, Brazil.
Thiago de Souza Dias SilvaDepartment of Organic Chemistry, Chemistry Institute, Federal Rural University of Rio de Janeiro, Seropédica 23890-000, Brazil.ORCID 0009-0009-6757-0490 Kátia da Silva CalabreseLaboratory of Protozoology, Oswaldo Cruz Institute, FIOCRUZ, Av. Brasil, 4.365, Manguinhos, Rio de Janeiro 21040-360, Brazil.
Flávia de Oliveira CardosoLaboratory of Protozoology, Oswaldo Cruz Institute, FIOCRUZ, Av. Brasil, 4.365, Manguinhos, Rio de Janeiro 21040-360, Brazil.ORCID 0000-0002-2026-1836 Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.475529/2020-00Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.408/2024National Council for Scientific and Technological Development 309493/2025-0National Council for Scientific and Technological Development 442053/2024-0
6 · The paper itselfAbstract
Chagas disease remains a major public health challenge due to the limited effectiveness and considerable side effects of existing treatments, particularly during the chronic stage. Açaí (
Indexed as
AçaíChagas diseaseEuterpe oleraceatreatmentTrypanosoma cruzi
Identifiers
PMID41514937
PMCPMC12785070
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390